Clinical trial
Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
NCT02259296 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
- Lead sponsor
- Shanghai Changzheng Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- December 31, 2017
- Enrollment
- 2,200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
renal failure, chronic